Literature DB >> 8570528

Gastrointestinal transit and distribution of ranitidine in the rat.

A B Suttle1, K L Brouwer.   

Abstract

PURPOSE: Ranitidine gastrointestinal distribution was examined in the rat small intestine after oral administration to determine whether intestinal transit or secretion (exsorption) may influence the appearance of secondary peaks in ranitidine serum concentration-time profiles.
METHODS: Male Sprague-Dawley rats received ranitidine (50 mg/kg) by oral gavage, and the mass of ranitidine recovered in all small intestinal segments (approximately 12 cm each) was determined 30, 60, 90, or 120 min after administration. In a separate group of anesthetized rats, the small intestine was divided into two segments of equal length that were perfused with normal saline in a single-pass manner. Rats received an escalating, zero-order IV infusion of ranitidine for 30 min, and venous blood and intestinal effluent were collected over 90 min to quantitate ranitidine exsorption.
RESULTS: Thirty min after oral administration, > 50% of the recovered ranitidine mass resided in the lower half of the small intestine in all rats. Ranitidine mass in 5 of 16 rats displayed a bimodal distribution with significant amounts of ranitidine recovered from the stomach 60 to 90 min after dosing. Ranitidine exsorption was more efficient from the lower jejunum and ileum than from the duodenum and upper jejunum. However, intestinal secretion of ranitidine was minor (5% of the IV dose).
CONCLUSIONS: Ranitidine absorption from the lower ileum contributes significantly to systemic ranitidine concentrations before and during the time of the first concentration maximum. Separation of the drug mass into multiple boluses may contribute to secondary peaks in ranitidine concentration-time profiles. Exsorption did not contribute significantly to ranitidine distribution in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570528     DOI: 10.1023/a:1016221606898

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Pharmacokinetics of pafenolol after i.v. and oral administration of three separate doses of different strength to man.

Authors:  C G Regardh; A Heggelund; K Kylberg-Hanssen; P Lundborg
Journal:  Biopharm Drug Dispos       Date:  1990-10       Impact factor: 1.627

2.  Effect of substance P on rat gastrointestinal transit.

Authors:  P Silkoff; F Karmeli; E Goldin; A Ewenson; C Gilon; M Chorev; R Laufer; Z Selinger; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

3.  Discontinuous oral absorption of cimetropium bromide, a new antispasmodic drug.

Authors:  B P Imbimbo; S Daniotti; A Vidi; D Foschi; F Saporiti; L Ferrante
Journal:  J Pharm Sci       Date:  1986-07       Impact factor: 3.534

4.  Study of the absorption site of cimetidine.

Authors:  N Kaneniwa; T Funaki; S Furuta; N Watari
Journal:  J Pharmacobiodyn       Date:  1986-03

5.  Ranitidine bioavailability and kinetics in normal male subjects.

Authors:  D C Garg; D J Weidler; F N Eshelman
Journal:  Clin Pharmacol Ther       Date:  1983-04       Impact factor: 6.875

6.  Regional gastrointestinal absorption of the beta-blocker pafenolol in the rat and intestinal transit rate determined by movement of 14C-polyethylene glycol (PEG) 4000.

Authors:  H Lennernäs; C G Regårdh
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

7.  Effect of dextromethorphan and levomethorphan on gastric emptying and intestinal transit in the rat.

Authors:  T S Gaginella; R J Bertko; J F Kachur
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

8.  Regional gastrointestinal absorption of ranitidine in the rat.

Authors:  A B Suttle; K L Brouwer
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

9.  Gastrointestinal transit and digestibility of maltitol, sucrose and sorbitol in rats: a multicompartmental model and recovery study.

Authors:  D Krüger; R Grossklaus; M Herold; S Lorenz; L Klingebiel
Journal:  Experientia       Date:  1992-08-15

10.  Small intestinal transit in the portal hypertensive rat.

Authors:  J A Reilly; E M Quigley; C F Forst; L F Rikkers
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

View more
  6 in total

1.  A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine.

Authors:  Ophelia Q P Yin; Brian Tomlinson; Albert H L Chow; Moses S S Chow
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

3.  Xiaotan Tongfu granules contribute to the prevention of stress ulcers.

Authors:  Bing Yan; Jun Shi; Li-Juan Xiu; Xuan Liu; Yu-Qi Zhou; Shou-Han Feng; Can Lv; Xiu-Xia Yuan; Yin-Cheng Zhang; Yong-Jin Li; Pin-Kang Wei; Zhi-Feng Qin
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 4.  Drug exsorption from blood into the gastrointestinal tract.

Authors:  K Arimori; M Nakano
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

5.  Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function.

Authors:  Yukiko Metsugi; Yoshihiro Miyaji; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2007-10-23       Impact factor: 4.200

Review 6.  Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?

Authors:  Christoph Wenzel; Marek Drozdzik; Stefan Oswald
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.